Published date: 19/09/2025

Our new recombinant Glucose Dehydrogenase enzyme

Advancing diabetes care, together

Our new recombinant Glucose Dehydrogenase enzyme

We’re excited to introduce a recombinant FAD-dependent Glucose Dehydrogenase (FAD-GDH) designed for use in continuous glucose monitoring devices – supporting more accurate and reliable diabetes management.

✔ Manufactured in the UK as a primary manufacturer

✔ Scalable to bulk quantities to meet global demand

✔ Verified in-application performance

✔ Samples now available

By combining scientific precision with scalable supply, we’re helping manufacturers bring better solutions to people living with diabetes.

Contact us to request samples.

Contact Us

SIGN-UP

Keep in touch

Put performance data, early reagent releases, and news & offers in your inbox. Join us in advancing health, together.

This field is for validation purposes and should be left unchanged.